ISSN:
1573-6903
Keywords:
MK-801
;
NMDA receptors
;
noncompetitive antagonist
;
E1 mice
;
epilepsy
;
glycine
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract Anticonvulsant action of MK-801, a novel noncompetitive antagonist of N-methyl-d-aspartate (NMDA) receptor, was examined in genetically epileptic E1 mice. Systemic injection of MK-801 (0.1–1.0 mg/kg) potently suppressed generalized tonic-clonic convulsions of in a dose-dependent manner (ED50, 0.17 mg/kg). This anticonvulsant effect of MK-801 appeared at a dose which did not induced any obvious behavioral changes. Following the administration of a fully anticonvulsant dose of MK-801 (1 mg/kg), amino acid analysis revealed a significantly elevated level of glycine in the hippocampus. Levels of other amino acids including glutamate, aspartate, taurine, glutamine, alanine, and γ-aminobutyrate were not changed either in the hippocampus or in the cerebral cortex. This study suggests that NMDA system may play an essential role in seizure-triggering mechanisms in E1 mouse.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF00964951
Permalink